Allarity Therapeutics, Inc. Uncategorized Contracts & Agreements
13 Contracts & Agreements
- First Comprehensive Amendment to At-The-Market Issuance Sales Agreement, dated May 17, 2024 (Filed With SEC on May 21, 2024)
- Fifth Certificate of Amendment to Certificate of Incorporation of Allarity Therapeutics, Inc (Filed With SEC on April 4, 2024)
- Form of Lock Up Agreement (Filed With SEC on December 15, 2023)
- Form of Lock Up Agreement (Filed With SEC on December 6, 2023)
- Form of Inducement Letter (Filed With SEC on September 15, 2023)
- Form of Lock-Up Agreement (Filed With SEC on June 30, 2023)
- FOURTHAMENDMENT TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on June 1, 2023)
- AMENDMENT TO MODIFICATIONAND EXCHANGE AGREEMENT (Filed With SEC on June 1, 2023)
- Cancellation of Debt Agreement (Filed With SEC on April 25, 2023)
- Form of Lock- Up (Filed With SEC on March 28, 2023)
- Letter Agreement with 3i, LP dated January 23, 2023 (Filed With SEC on March 13, 2023)
- Letter Agreement with 3i, LP (Filed With SEC on March 13, 2023)
- Support Agreement between Allarity Therapeutics A/S and LiPlasome Pharma ApS, dated March 28, 2022 (Filed With SEC on May 17, 2022)
